UAE Heart Failure Treatment Drugs (UAE HFTD) Market Analysis-2027

1. UAE HEART FAILURE DRUGS TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION UAE Heart Failure Treatment Drugs Market - Overview UAE Heart Failure Treatment Drugs Market, by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) is estimated to be valued at US$ 62.8 million in 2020 and is expected to exhibit a CAGR of 6.5% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. UAE Heart Failure Treatment Drugs Market: Drivers The increasing healthcare expenditure is expected to drive the UAE heart failure treatment drugs market growth during the forecast period. According to the Healthcare Resource Guide: United Arab Emirates report published in October 2019, the UAE’s healthcare expenditure reached US$ 14.4 billion in 2019 which was an increase of 5.4% compared to 2018. According to World Health Organization – Non-communicable Diseases (NCD) Country Profiles, in 2018, cardiovascular disease was the leading cause of death in the UAE, and accounted for 40% of all mortalities. Moreover, the growing prevalence of cardiovascular diseases in UAE is expected to increase the risk of heart failure. Factors such as sedentary lifestyle, smoking and unhealthy diet are increasing the risk of heart failure among the Middle Eastern populatio. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/uae- heart-failure-drugs-treatment-market-4172 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION UAE Heart Failure Treatment Drugs Market: Opportunities Even with the rapid expansion and increasing competition in pharmaceutical manufacturing, UAE has to import 80% of medicines to address the drug demand in the country. In 2018, a new regulation for prescribing generics was introduced in Abu Dhabi which stated that all pharmacies must dispense generic medicines to all patients; and those who want the branded medication must pay the different prices, which can be up to 70% more than that of generics. This is expected to boost growth of the local and regional pharmaceutical industry to offer customers more choices for medicinal products within affordable price ranges. UAE Heart Failure Treatment Drugs Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe with the World Health Organization declaring it a public health emergency. According to the World Health Organization’s report, manifestation of the coronavirus disease (COVID-19) has resulted in more than 26.1 million infected individuals worldwide as of September 2020. COVID-19 has affected the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4172 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The coronavirus (COVID 19) pandemic and resulting lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare sector has been impacted significantly by the pandemic. Browse 06 Market Data Tables and 16 Figures spread through 112 Pages and in-depth TOC on “UAE Heart Failure Treatment Drugs Market, by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). Key Takeaways of the UAE Heart Failure Treatment Drugs Market: The UAE Heart Failure Treatment Drugs Market is expected to exhibit a CAGR of 5% during the forecast period owing to robust product pipeline and increasing approval of new heart failure drugs. Among drug class, the ACE inhibitors segment is expected to hold a dominant position in the UAE heart failure treatment drugs market in 2027 owing to launch of new and advanced products by market players. Among distribution channel, hospital pharmacies segment is expected to hold dominant position in the UAE heart failure treatment drugs market in 2027, as hospital pharmacies are mainly associated with hospitals to procure medications for in-patients and out-patients. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4172 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved